These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18254957)

  • 1. Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter.
    Fang F; Antico G; Zheng J; Clevenger CV
    BMC Biotechnol; 2008 Feb; 8():11. PubMed ID: 18254957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.
    Fang F; Rycyzyn MA; Clevenger CV
    Endocrinology; 2009 Apr; 150(4):1597-606. PubMed ID: 19036881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of prolactin receptor in GH signaling in breast cancer cells.
    Xu J; Sun D; Jiang J; Deng L; Zhang Y; Yu H; Bahl D; Langenheim JF; Chen WY; Fuchs SY; Frank SJ
    Mol Endocrinol; 2013 Feb; 27(2):266-79. PubMed ID: 23192981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
    Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
    Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.
    Linher-Melville K; Singh G
    BMC Cancer; 2014 Jun; 14():415. PubMed ID: 24913037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOCS3 as a tumor suppressor in breast cancer cells, and its regulation by PRL.
    Barclay JL; Anderson ST; Waters MJ; Curlewis JD
    Int J Cancer; 2009 Apr; 124(8):1756-66. PubMed ID: 19115200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global profiling of prolactin-modulated transcripts in breast cancer in vivo.
    Sato T; Tran TH; Peck AR; Liu C; Ertel A; Lin J; Neilson LM; Rui H
    Mol Cancer; 2013 Jun; 12():59. PubMed ID: 23758962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRL/PRLR Can Promote Insulin Resistance by Activating the JAK2/STAT5 Signaling Pathway.
    Wang PY; Jin CC; Liu C; Zhao ZJ; Yang HY
    Comput Math Methods Med; 2022; 2022():1456187. PubMed ID: 36238467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of multidrug resistance transporter ABCG2 by prolactin in human breast cancer cells.
    Wu AM; Dalvi P; Lu X; Yang M; Riddick DS; Matthews J; Clevenger CV; Ross DD; Harper PA; Ito S
    Mol Pharmacol; 2013 Feb; 83(2):377-88. PubMed ID: 23150485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a rat uterine cell line, U(III) cells: prolactin (PRL) expression and endogenous regulation of PRL-dependent genes; estrogen receptor beta, alpha(2)-macroglobulin, and decidual PRL involving the Jak2 and Stat5 pathway.
    Prigent-Tessier A; Barkai U; Tessier C; Cohen H; Gibori G
    Endocrinology; 2001 Mar; 142(3):1242-50. PubMed ID: 11181541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone H1 and Chromosomal Protein HMGN2 Regulate Prolactin-induced STAT5 Transcription Factor Recruitment and Function in Breast Cancer Cells.
    Schauwecker SM; Kim JJ; Licht JD; Clevenger CV
    J Biol Chem; 2017 Feb; 292(6):2237-2254. PubMed ID: 28035005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.
    Pedraz-Cuesta E; Fredsted J; Jensen HH; Bornebusch A; Nejsum LN; Kragelund BB; Pedersen SF
    Mol Endocrinol; 2016 Jul; 30(7):693-708. PubMed ID: 27176613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor.
    Carsol JL; Gingras S; Simard J
    Mol Endocrinol; 2002 Jul; 16(7):1696-710. PubMed ID: 12089361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation.
    Goupille O; Daniel N; Bignon C; Jolivet G; Djiane J
    Mol Cell Endocrinol; 1997 Mar; 127(2):155-69. PubMed ID: 9099911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha
    Castillo LF; Rivero EM; Goffin V; Lüthy IA
    Cell Signal; 2017 Jun; 34():76-85. PubMed ID: 28302567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases.
    Leung KC; Brce J; Doyle N; Lee HJ; Leong GM; Sjögren K; Ho KK
    Endocrinology; 2007 May; 148(5):2417-23. PubMed ID: 17272397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathways.
    Um M; Lodish HF
    J Biol Chem; 2006 Mar; 281(9):5648-56. PubMed ID: 16407271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CISH has no non-redundant functions in glucose homeostasis or beta cell proliferation during pregnancy in mice.
    Jiao Y; Rieck S; Le Lay J; Kaestner KH
    Diabetologia; 2013 Nov; 56(11):2435-45. PubMed ID: 23949579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximal expression of suppressors of cytokine signaling in the rat ovary occurs in late pregnancy.
    Anderson ST; Isa NN; Barclay JL; Waters MJ; Curlewis JD
    Reproduction; 2009 Sep; 138(3):537-44. PubMed ID: 19502454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.